As announced by Lexin Medical, the company previously disclosed the share of assets pledged and paid for by Shanghai Houxue Private Equity Fund partnership of RMB 10 million to be held by Suzhou Houxue. On September 7, 2026, the board of directors of the company reviewed and approved the adjustment plan. The original transfer was no longer implemented. Instead, the share of the fund was subscribed by means of a capital increase. The proposed subscription share is still RMB 10 million, and the proposed capital amount consists of RMB 10 million and deferred compensation.

As announced by Lexin Medical, the company previously disclosed the share of assets pledged and paid for by Shanghai Houxue Private Equity Fund partnership of RMB 10 million to be held by Suzhou Houxue. On September 7, 2026, the board of directors of the company reviewed and approved the adjustment plan. The original transfer was no longer implemented. Instead, the share of the fund was subscribed by means of a capital increase. The proposed subscription share is still RMB 10 million, and the proposed capital amount consists of RMB 10 million and deferred compensation.